Literature DB >> 2893198

Risk estimation and screening in families of patients with medullary thyroid carcinoma.

B A Ponder1, M A Ponder, R Coffey, M E Pembrey, R F Gagel, M Telenius-Berg, P Semple, D F Easton.   

Abstract

Many gene carriers for multiple endocrine neoplasia type 2a (MEN 2a) do not manifest the disease, even into old age. Thus, a negative family history in a patient presenting with medullary thyroid carcinoma does not reliably exclude familial disease. Data are reported for the probability that the MEN 2a gene will either have manifested clinically or be detectable by stimulated calcitonin screening by a given age. These probabilities can be used to calculate individual risks and to guide screening.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893198     DOI： 10.1016/s0140-6736(88)91191-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  24 in total

1.  (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.

Authors:  Maya Lodish; Urania Dagalakis; Clara C Chen; Ninet Sinaii; Patricia Whitcomb; Alberta Aikin; Eva Dombi; Leigh Marcus; Brigitte Widemann; Elizabeth Fox; Meredith Chuk; Frank Balis; Samuel Wells; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-12-07       Impact factor: 5.958

2.  Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.

Authors:  S A Narod; H Sobol; Y Nakamura; C Calmettes; J L Baulieu; J C Bigorgne; G Chabrier; J Couette; J L de Gennes; J Duprey
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

3.  Early diagnosis of multiple endocrine neoplasia type IIa.

Authors:  H P Neumann; O A Müller; B A Ponder; C G Mathew; H Telenius; W Schempp; C Schuemichen; N Freudenberg; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1989-09-15

4.  Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression.

Authors:  L M McGregor; B K McCune; J R Graff; P R McDowell; K E Romans; G D Yancopoulos; D W Ball; S B Baylin; B D Nelkin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 5.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

6.  Oncological implications of RET gene mutations in Hirschsprung's disease.

Authors:  R H Sijmons; R M Hofstra; F A Wijburg; T P Links; R P Zwierstra; A Vermey; D C Aronson; G Tan-Sindhunata; G J Brouwers-Smalbraak; S M Maas; C H Buys
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

7.  Genetic analysis of 24 French families with multiple endocrine neoplasia type 2A.

Authors:  S A Narod; M F Lavoué; K Morgan; C Calmettes; H Sobol; P J Goodfellow; G M Lenoir
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

8.  A Korean family of familial medullary thyroid cancer with Cys618Ser RET germline mutation.

Authors:  Jinhyang Jung; Shinya Uchino; Youngha Lee; Hoyong Park
Journal:  J Korean Med Sci       Date:  2010-01-21       Impact factor: 2.153

9.  Medullary carcinoma of the thyroid presenting as multifocal bronchial carcinoid tumour.

Authors:  J E Clague; M G Pearson; A Sharma; W Taylor
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

10.  [Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

Authors:  A Frilling; P E Goretzki; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1990
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.